PITTSBURGH, Sept. 13 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region's life sciences industry on a fast track for growth, announced that Peter M. DeComo, Chairman and Chief Executive Officer, Renal Solutions, Inc., John A. Kuzmishin, Vice President of Strategic Business Initiatives, UPMC, John L. Miclot, President and Chief Executive Officer, Respironics, and Elizabeth S. Woo, Ph. D., Vice President, Biotechnology, Thermo Fisher Scientific have been elected to the PLSG Board of Directors.
"We are extremely honored that Mr. DeComo, Mr. Kuzmishin, Mr. Miclot and Dr. Woo have agreed to join our board of directors. Their business experience with life science organizations, combined with their significant credentials and achievements, make them a tremendous asset to help guide the PLSG in our efforts to continue to drive innovation and commercialize more life sciences technologies in the region," said John W. Manzetti, PLSG's President and CEO.
About Peter M. DeComo
Mr. DeComo, is a co-founder of Renal Solutions, Inc. (RSI), an innovator in the development of renal dialysis systems for both the institutional and home environments. He serves as the company's Chairman and Chief Executive Officer. Before co-founding RSI, he was the Chief Operating Officer of HemoTherapies Inc., a start-up company in San Diego, commercializing the only FDA cleared Liver Dialysis System. He was previously Senior Vice President of the Specialty Pharmacy Division for Olsten Health Services, now Accredo, a $600 million specialty pharmacy provider. Prior to joining Olsten, Mr. DeComo held numerous senior level positions in the health care industry, launching and commercializing specialized products and services to patients in the home setting. He has served as a Director on the Board of Curative Health Services and is affiliated with a number of healthcare related organizations and advocacy groups. Mr. DeComo received his MS and BS degrees in Healthcare/Business Management from the University of Pittsburgh.
About John A. Kuzmishin
Mr. Kuzmishin is a senior member of the Strategic Business Initiatives group at the University of Pittsburgh Medical Center. His responsibilities include sourcing, structuring and overseeing direct investments as well as general business development for UPMC. Prior to joining UPMC in 2004, Mr. Kuzmishin spent 15 years as a healthcare investment banker, most recently as head of the healthcare investment banking group at Robert W. Baird & Co. (1996 - 2004). Prior to Baird he worked in the investment banking groups at Vector Securities International (1990 - 1996) and Shearson, Lehman Hutton Inc. (1988 - 1990). Mr. Kuzmishin graduated Phi Beta Kappa with honors from The College of Wooster in 1988 earning a Bachelor of Arts in Business Economics.
About John L. Miclot
John L. Miclot became President and CEO of Respironics, Inc., on December 1, 2003. In November 2002 he was appointed the company's Chief Strategic Officer responsible for developing and implementing strategic business and growth initiatives, both domestically and internationally, for each of Respironics' four divisions. In May 2003, he was elected to the Board of Directors. Prior to his position as Chief Strategic Officer he was the President of the Homecare Division from July 1999 to November 2002, where he oversaw strategic direction, sales and marketing, operations as well as research and development for the company's largest division. Miclot joined Respironics in 1998 when it acquired Healthdyne Technologies where he had served as Senior Vice President, Sales and Marketing from 1995-1998. He was appointed Group Vice President, Sleep Disorders, and was quickly promoted to Senior Vice President, Sales, Marketing and Manufacturing.
About Elizabeth S. Woo, Ph.D.
As Vice-President of Sales, Biotechnology Market & Application Specialists Program for Thermo Fisher Scientific, Dr. Woo is responsible for all aspects of sales to the biotechnology/ biopharmaceutical market segment, including sales expenditures, business development, P&L, pricing and financial modeling, contracting, forecasting and territory development. Prior to becoming Vice President, Dr. Woo held positions as Director of Marketing, Senior Director of Business Development, Senior Director of Technical Marketing and Product Manager. Dr. Woo is also an accomplished Bench Scientist. She possesses a Doctorate in Pharmacology from George Washington University Medical Center and a Bachelor of Science Degree in Biological Sciences from Carnegie Mellon University.
About the Pittsburgh Life Sciences Greenhouse (PLSG)
The PLSG invests in and supports the growth of biosciences companies in southwestern Pennsylvania. The PLSG has investment and business growth programs to increase the linkage between research, technology and commercialization; nurture and develop entrepreneurial biosciences enterprises; grow the region's talent pool in the life sciences; and help biosciences firms locate, expand or start-up in the Greater Pittsburgh region. http://www.plsg.com
Pittsburgh Life Sciences Greenhouse